David Evans, PhD, Department of Pathology and Laboratory Medicine, was recently awarded a new R01 grant from NIH along with Co-Investigator Christian Capitini, MD, associate professor, Hematology, Oncology, and Bone Marrow Transplant. This five-year award (with Year 1 funding in the amount of $764,536), is titled “Harnessing adaptive NK cell transfer to deplete viral reservoirs.” The proposed study, funded by the National Institutes of Health/National Institute of Allergy and Infectious Diseases, will reveal the extent to which viral peptides presented on the surface of HIV-infected cells stimulate natural killer (NK) cell responses through activating receptors. It will provide an important proof-of-concept for the development of NK cell-based therapies to eradicate HIV-1 reservoirs in chronically infected individuals.